A transcriptome-based signature of pathological angiogenesis predicts breast cancer patient survival
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified distinct genes in pathological angiogenesis using a mouse model. These genes predict breast cancer patient survival, offering new therapeutic strategies for angiogenesis-dependent diseases.
Area Of Science
- Molecular Biology
- Oncology
- Ophthalmology
Background
- Physiological and pathological angiogenesis involve different genes and molecules.
- Understanding pathological angiogenesis is crucial for treating related diseases.
Purpose Of The Study
- To identify genes and pathways specific to pathological angiogenesis.
- To explore the utility of these genes in cancer patient stratification.
Main Methods
- Transcriptome analysis of mouse retina in oxygen-induced retinopathy (OIR) model.
- Identification of differentially expressed genes between normal and OIR retinas.
- Validation of gene signature in an independent breast cancer patient cohort.
Main Results
- 153 genes were identified as differentially expressed in the OIR mouse retina.
- These genes form a molecular signature relevant to angiogenesis-dependent processes like cancer.
- The identified gene signature significantly predicted breast cancer patient survival.
Conclusions
- The OIR model effectively reveals key genes in pathological angiogenesis.
- These findings suggest potential applications in stratifying cancer patients for targeted therapies.
- The study highlights the link between retinal angiogenesis and cancer progression.

